INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

14 Feb 2023 07:00:33 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference

08 Feb 2023 07:00:59 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 Jan 2023 07:00:24 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights New CAPLYTA Bipolar Depression Data Presentations at the American College of Neuropsychopharmacology 61st Annual Meeting

08 Dec 2022 07:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences

10 Nov 2022 07:00:03 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

03 Nov 2022 06:30:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call and Webcast

27 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 Aug 2022 06:30:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call and Webcast

02 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience

13 Jun 2022 07:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

10 May 2022 06:30:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast

03 May 2022 07:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations

25 Apr 2022 06:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors

21 Apr 2022 07:00:02 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Conference

05 Apr 2022 07:00:03 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

01 Mar 2022 06:30:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast

22 Feb 2022 07:00:02 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

10 Feb 2022 07:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

07 Jan 2022 15:01:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Prices Public Offering of Common Stock

04 Jan 2022 21:08:26 By Nasdaq GlobeNewswire